BusinessCircleBusinessCircle
  • Home
  • SMEs
  • Startups
  • Markets
  • Finances
  • HR
  • Marketing & Sales
  • Technology
Facebook Twitter Instagram
Monday, June 2
  • About us
  • Advertise with us
  • Submit Articles
  • Privacy Policy
  • Contact us
BusinessCircleBusinessCircle
  • Home
  • SMEs
  • Startups
  • Markets
  • Finances
  • HR
  • Marketing & Sales
  • Technology
Subscribe
BusinessCircleBusinessCircle
Finances

Deepak Fertilisers rallies 6%, hits new high on strong demand outlook

Business CircleBy Business CircleOctober 20, 2022No Comments3 Mins Read

[ad_1]

Shares of Deepak Fertilisers & Petrochemicals Company (DFPCL) hit a brand new excessive of Rs 1,048 as they rallied 6 per cent on the BSE in Thursday’s intra-day commerce, in an in any other case range-bound market, on robust demand outlook. The inventory of the main producers of commercial chemical substances and fertilisers firm was buying and selling increased for the fourth straight day, surging 17 per cent throughout the interval. Compared, the S&P BSE Sensex was down 0.10 per cent at 59,047 factors at 01:18 PM.


DFPCL is the second largest producer of Nitric Acid in South East Asia, and the most important in India. The corporate is the main producer and marketer of Iso Propyl Alcohol (IPA), largest producer of Bentonite Sulphur, and a market chief in specialty and water-soluble fertilisers in India. It’s establishing a 5.1 lakh MTPA ammonia facility close to its present operations at Taloja for backward integration. The undertaking is predicted to get commissioned by Q1FY24.


In April-June quarter (Q1FY23), DFPCL had reported 233 per cent year-on-year (YoY) bounce in its consolidated revenue after tax (PAT) at Rs 436 crore, on the again of 59 per cent YoY development in income of Rs 3,031 crore. Working EBITDA margins had elevated from 15.2 per cent in Q1FY22 to 24.3 per cent in Q1FY23.


The corporate’s market management in key product segments and powerful demand outlook is predicted to drive enterprise development and profitability. With a constructive outlook for mining, infrastructure and energy sector, the corporate expects to learn from elevated Technical Ammonium Nitrate (TAN) demand, a development that’s prone to maintain.


“Greater reservoir ranges and applicable monsoon protection in our core command area is being witnessed. Consumption in Q2 is predicted to extend supported by increased commodity costs for money crops because of strong weather conditions,” DFPCL’s administration had stated whereas asserting Q1 outcomes on July 19.


Lengthy-term development is predicted to be underpinned by change in product combine, head room availability of further capacities rising from higher operational administration, and debottlenecking together with greenfield expansions, the administration had stated.


“The demand and costs for nitric acid are anticipated to stay robust owing to diminishing availability of down streams of from China and resultant increased pricing. The shift of world provide chain development in the direction of India will proceed to drive robust demand of Nitric Acid from downstream clients. The IPA small pack demand each from Pharma and LR grade are anticipated to stay robust,” the corporate stated of their FY22 annual report.


“Robust income and regular margin might drive a 17.5 per cent CAGR in web revenue over the following two years. The long-term development of the corporate is predicted to be underpinned by a change in its product combine, head room availability of further capacities rising from higher operational administration and de-bottlenecking, together with greenfield expansions. A few of the key positives embrace robust development prospects of the TAN enterprise, excessive regulatory entry limitations, bettering capability utilisations, and a powerful uptick in return ratios,” HDFC Securities stated in its Diwali picks.

[ad_2]

Source link

Deepak demand Fertilisers High hits outlook rallies Strong
Business Circle
  • Website

Related Posts

US manufacturing output increases in March; February data revised higher

April 16, 2024

AbbVie to spend $1.9B for long acting injectables (NYSE:ABBV)

April 16, 2024

‘Febrile’ excitement helping early stage AI keep pace with the U.S.

April 16, 2024

Johnson & Johnson (JNJ) earnings Q1 2024

April 16, 2024
Add A Comment

Leave A Reply Cancel Reply

Recent Posts
  • Code promo Betify – Profitez d_offres exclusives pour vos paris sportifs
  • Hanf�l mit CBD f�r den Hund kaufen
  • Top 10 ajánlás a virtuális kaszinókban való nyeréshez
  • Chicken Road Online-casino: Spaß Ferner Spannung Für Deutschland
  • 20bet Nasze Państwo ᐉ Kasyno Internetowego I Zakłady Sportowe 2025
© 2025 BusinessCircle.co
  • Home
  • Disclaimer
  • Privacy Policy
  • DMCA
  • Cookie Privacy Policy
  • Terms and Conditions
  • Contact us

Type above and press Enter to search. Press Esc to cancel.